Optimapharm
OptimaOnco Suite
Partnered on
83
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
81
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Approved Oncology Therapies

OptimaOnco Suite introduces a fully integrated oncology Full Service CRO ecosystem that brings together world-class clinical experts, expansive site networks, strategic technology partners, advanced data visualisation and the patient voice into one seamless offering. Designed to deliver greater efficiency, accelerate study start-up, enhance evidence generation and elevate the patient experience, it breaks the mould of the traditional CRO model. By connecting every stakeholder across the oncology journey, OptimaOnco Suite transforms complexity into coordinated, patient-centred progress

230+ Oncology Projects
10,000+ Subjects Enrolled
OptimaOnco Suite Distribution

Strategic Advisory Board

Dr. Pavle Vukojević

Dr. Pavle Vukojević

Chief Medical Officer

Dr. Ignacio Garcia-Ribas

Dr. Ignacio Garcia-Ribas

Medical Advisor

Dr. Siniša Radulović

Dr. Siniša Radulović

Medical Advisor

Dr. Gail L. Brown

Dr. Gail L. Brown

Medical Advisor

Fuentsanta Bellvis Bataller

Fuentsanta Bellvis Bataller

Clinical Imaging

Patient Advisory Board

Optimapharm has established a dedicated Patient Advisory Board, which we actively collaborate with and support to ensure patients' perspectives are reflected throughout development. By embedding their voice into clinical trial protocols and study execution, we help shape research that is more accessible, meaningful and aligned with the needs of those it aims to serve

Patient Advisory Board
Sandra Silva-Arrieta - Patient Advisory Board Lead

We Proudly Support

Stupid Cancer – We Proudly Support

Site & Patient Referral Networks

Optimapharm strategically partners with diverse site networks, including community-based recruitment organisations, site management organisations, and leading hospital systems, to deliver faster and more seamless study execution. With twice the reach across North America and Europe compared with the average mid-sized CRO, we expand access to patients where they live and receive care, enabling broader enrolment and real-world representation. These collaborative partnerships drive accelerated start-up, stronger referral pathways and a consistently high-performing site experience.

Site & Patient Referral Networks Map
Accelerated START-UP
Growth Chart

2xThe reach of the average mid-sized CRO in North America and Europe

Healthcare Professional

Accelerating delivery through patient reach and expanded access to regulatory frameworks

Data Visualisations

BI Wizard

BI Wizard is our custom-built analytics solution, developed and powered by Microsoft Power BI. It leverages Power BI's robust business intelligence platform to visualise data, share insights, and provide interactive dashboards and reports. With BI Wizard, both Optimapharm and our sponsors can easily explore and interact with data, supporting informed, data-driven decision-making on all sides

Operational Insights

Example Report (Enrolment)
Enrolment Report

Patient Profiling

Example Report (Blood Pressure)
Blood Pressure

Endpoint & Outcome Measures

Central Imaging

Central Imaging
Imaging endpoints assessment and centralized reads
End-to-end imaging platform
AI-powered technology to extract exploratory imaging endpoints
STRATEGIC PARTNER
Quibim

Central Laboratory

Central Laboratory
CAP Certified global laboratories
Health Institution for LDT/IVDR
PBMC Network
Large range of Broad Biomarker Capabilities
STRATEGIC PARTNER
mlm medical labs

Resource Hub